Annual Working Capital
$22.52 M
-$100.54 M-81.70%
December 31, 2023
Summary
- As of February 8, 2025, RNAC annual working capital is $22.52 million, with the most recent change of -$100.54 million (-81.70%) on December 31, 2023.
- During the last 3 years, RNAC annual working capital has fallen by -$47.28 million (-67.73%).
- RNAC annual working capital is now -81.70% below its all-time high of $123.06 million, reached on December 31, 2022.
Performance
RNAC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$207.73 M
+$109.06 M+110.54%
September 1, 2024
Summary
- As of February 8, 2025, RNAC quarterly working capital is $207.73 million, with the most recent change of +$109.06 million (+110.54%) on September 1, 2024.
- Over the past year, RNAC quarterly working capital has increased by +$133.28 million (+179.00%).
- RNAC quarterly working capital is now at all-time high.
Performance
RNAC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
RNAC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -81.7% | +179.0% |
| 3 y3 years | -67.7% | +68.8% |
| 5 y5 years | +224.9% | +68.8% |
RNAC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.7% | at low | at high | +822.4% |
| 5 y | 5-year | -81.7% | at low | at high | +822.4% |
| alltime | all time | -81.7% | +224.9% | at high | +3028.0% |
Cartesian Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $207.73 M(+110.5%) |
| Jun 2024 | - | $98.67 M(+32.5%) |
| Mar 2024 | - | $74.45 M(+230.6%) |
| Dec 2023 | $22.52 M(-81.7%) | $22.52 M(-67.8%) |
| Sep 2023 | - | $69.93 M(-25.1%) |
| Jun 2023 | - | $93.36 M(-16.5%) |
| Mar 2023 | - | $111.86 M(-9.1%) |
| Dec 2022 | $123.06 M(+70.5%) | - |
| Dec 2022 | - | $123.06 M(-9.5%) |
| Sep 2022 | - | $135.95 M(-2.1%) |
| Jun 2022 | - | $138.81 M(+52.9%) |
| Mar 2022 | - | $90.76 M(+25.7%) |
| Dec 2021 | $72.19 M(+3.4%) | $72.19 M(+28.6%) |
| Sep 2021 | - | $56.15 M(-29.4%) |
| Jun 2021 | - | $79.52 M(+1.3%) |
| Mar 2021 | - | $78.52 M(+12.5%) |
| Dec 2020 | $69.80 M | $69.80 M(-22.0%) |
| Sep 2020 | - | $89.50 M(+132.2%) |
| Jun 2020 | - | $38.54 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $44.37 M(-28.1%) |
| Dec 2019 | $61.72 M(+790.4%) | $61.72 M(+829.4%) |
| Sep 2019 | - | $6.64 M(-47.0%) |
| Jun 2019 | - | $12.54 M(-52.6%) |
| Mar 2019 | - | $26.48 M(+282.0%) |
| Dec 2018 | $6.93 M(-92.1%) | $6.93 M(-66.9%) |
| Sep 2018 | - | $20.94 M(-61.9%) |
| Jun 2018 | - | $54.94 M(-24.9%) |
| Mar 2018 | - | $73.17 M(-16.6%) |
| Dec 2017 | $87.71 M(+20.0%) | $87.71 M(-8.7%) |
| Sep 2017 | - | $96.03 M(+1.6%) |
| Jun 2017 | - | $94.53 M(+62.5%) |
| Mar 2017 | - | $58.18 M(-20.4%) |
| Dec 2016 | $73.11 M(+131.2%) | $73.11 M(-3.4%) |
| Sep 2016 | - | $75.71 M(-5.5%) |
| Jun 2016 | - | $80.11 M(+239.9%) |
| Mar 2016 | - | $23.57 M(-25.5%) |
| Dec 2015 | $31.62 M(+220.0%) | $31.62 M |
| Dec 2014 | $9.88 M | - |
FAQ
- What is Cartesian Therapeutics annual working capital?
- What is the all time high annual working capital for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual working capital year-on-year change?
- What is Cartesian Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly working capital year-on-year change?
What is Cartesian Therapeutics annual working capital?
The current annual working capital of RNAC is $22.52 M
What is the all time high annual working capital for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual working capital is $123.06 M
What is Cartesian Therapeutics annual working capital year-on-year change?
Over the past year, RNAC annual working capital has changed by -$100.54 M (-81.70%)
What is Cartesian Therapeutics quarterly working capital?
The current quarterly working capital of RNAC is $207.73 M
What is the all time high quarterly working capital for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly working capital is $207.73 M
What is Cartesian Therapeutics quarterly working capital year-on-year change?
Over the past year, RNAC quarterly working capital has changed by +$133.28 M (+179.00%)